IRLAB Therapeutics AB

Dec 08, 2020

IRLAB strengthens patent protection for Phase IIb/III drug candidate mesdopetam

Sep 10, 2020

IRLAB's drug candidate pirepemat featured on cover of top-tier journal JPET

Aug 03, 2020

IRLAB's IRL752 is proposed pirepemat as a unique INN by WHO

Jul 09, 2020

IRLAB's Clinical Drug Candidate IRL752 Published in JPET

Jun 04, 2020

IRLAB's Phase IIb/III Study in Parkinson's disease to Target Good ON

Mar 23, 2020

IRLAB's Phase IIa Study with IRL752 is Published in Movement Disorders